Learn More About Our Innovative Biotechnology
Press Releases, Publications, & Videos
Full Enrollment of First Cohort of Relapsed/Refractory Non-Hodgkin’s Lymphoma Patients dosed with AVM0703
Press Release
Theresa Deisher Speaks at ESWI Influenza Conference
Video
AVM Biotechnology – The Platform Therapy for Immune Modulation
Publication
Pharma’s Almanac Features AVM0703
Publication
AVM Biotechnology CEO/CSO Selected to Speak at ESWI Conference in Novel and Outstanding Discoveries Track
Press Release
What is AVM0703? Find Out!
Video
President Receives Dexamethasone Treatment
Press Release
AVM Receives FDA Permission for Clinical Trials in COVID-19/ARDS
Press Release
AVM Expands Executive Team, Appoints Janet R. Rea COO
Press Release
Amplifying Scientific Innovation Podcast
Video
AVM’s Dexamethasone Formulation Has Potential For Greater Impact Than Oxford’s
Press Release
Oxford/AVM’s potential COVID-19 Treatment Featured on KOMO News
Video
AVM Awarded SBIR Grant From National Cancer Institute
Press Release
FDA Approves AVM0703 Clinical Trials in R/R Non-Hodgkins Lymphoma
Press Release
Cavendish Global 2020
Video